Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 3, p. 138, doi. 10.1002/clc.22692
- By:
- Publication type:
- Article
Works matching IS 01609289 AND DT 2017 AND VI 40 AND IP 3
Results: 8
1
2
Changes in left ventricular function after spontaneous coronary artery dissection.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 3, p. 149, doi. 10.1002/clc.22640
- By:
- Publication type:
- Article
3
Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed-care population.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 3, p. 155, doi. 10.1002/clc.22641
- By:
- Publication type:
- Article
4
Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis ( MESA).
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 3, p. 163, doi. 10.1002/clc.22642
- By:
- Publication type:
- Article
5
Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 3, p. 170, doi. 10.1002/clc.22643
- By:
- Publication type:
- Article
6
Heart Rhythm Society: expert consensus statements-part 2.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 3, p. 186, doi. 10.1002/clc.22665
- By:
- Publication type:
- Article
7
Heart Rhythm Society: expert consensus statements-part 1.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 3, p. 177, doi. 10.1002/clc.22666
- By:
- Publication type:
- Article
8
Issue Information.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 3, p. 133, doi. 10.1002/clc.22618
- Publication type:
- Article